↓ Skip to main content

Alternative functional in vitro models of human intestinal epithelia

Overview of attention for article published in Frontiers in Pharmacology, January 2013
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (82nd percentile)
  • High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter
1 X user
patent
2 patents
facebook
1 Facebook page

Readers on

mendeley
447 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Alternative functional in vitro models of human intestinal epithelia
Published in
Frontiers in Pharmacology, January 2013
DOI 10.3389/fphar.2013.00079
Pubmed ID
Authors

Amanda L. Kauffman, Alexandra V. Gyurdieva, John R. Mabus, Chrissa Ferguson, Zhengyin Yan, Pamela J. Hornby

Abstract

Physiologically relevant sources of absorptive intestinal epithelial cells are crucial for human drug transport studies. Human adenocarcinoma-derived intestinal cell lines, such as Caco-2, offer conveniences of easy culture maintenance and scalability, but do not fully recapitulate in vivo intestinal phenotypes. Additional sources of renewable physiologically relevant human intestinal cells would provide a much needed tool for drug discovery and intestinal physiology. We compared two alternative sources of human intestinal cells, commercially available primary human intestinal epithelial cells (hInEpCs) and induced pluripotent stem cell (iPSC)-derived intestinal cells to Caco-2, for use in in vitro transwell monolayer intestinal transport assays. To achieve this for iPSC-derived cells, intestinal organogenesis was adapted to transwell differentiation. Intestinal cells were assessed by marker expression through immunocytochemical and mRNA expression analyses, monolayer integrity through Transepithelial Electrical Resistance (TEER) measurements and molecule permeability, and functionality by taking advantage the well-characterized intestinal transport mechanisms. In most cases, marker expression for primary hInEpCs and iPSC-derived cells appeared to be as good as or better than Caco-2. Furthermore, transwell monolayers exhibited high TEER with low permeability. Primary hInEpCs showed molecule efflux indicative of P-glycoprotein (Pgp) transport. Primary hInEpCs and iPSC-derived cells also showed neonatal Fc receptor-dependent binding of immunoglobulin G variants. Primary hInEpCs and iPSC-derived intestinal cells exhibit expected marker expression and demonstrate basic functional monolayer formation, similar to or better than Caco-2. These cells could offer an alternative source of human intestinal cells for understanding normal intestinal epithelial physiology and drug transport.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 447 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 11 2%
Mexico 3 <1%
Brazil 3 <1%
United Kingdom 2 <1%
Italy 1 <1%
France 1 <1%
Ghana 1 <1%
Hong Kong 1 <1%
Germany 1 <1%
Other 8 2%
Unknown 415 93%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 122 27%
Student > Master 73 16%
Researcher 67 15%
Student > Bachelor 42 9%
Student > Doctoral Student 25 6%
Other 69 15%
Unknown 49 11%
Readers by discipline Count As %
Agricultural and Biological Sciences 118 26%
Medicine and Dentistry 49 11%
Engineering 33 7%
Biochemistry, Genetics and Molecular Biology 32 7%
Social Sciences 24 5%
Other 124 28%
Unknown 67 15%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 17 May 2022.
All research outputs
#4,496,252
of 22,713,403 outputs
Outputs from Frontiers in Pharmacology
#1,898
of 15,940 outputs
Outputs of similar age
#48,354
of 280,747 outputs
Outputs of similar age from Frontiers in Pharmacology
#24
of 167 outputs
Altmetric has tracked 22,713,403 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 15,940 research outputs from this source. They receive a mean Attention Score of 4.9. This one has done well, scoring higher than 88% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 280,747 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 82% of its contemporaries.
We're also able to compare this research output to 167 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 85% of its contemporaries.